Long-chain hydroxydicarboxylic aciduria, carnitine depletion and acetaminophen exposure.
Nowaczyk
M J
MJ
Department of Molecular Medicine and Pathology, McMaster University, Hamilton, Ontario, Canada. nowaczyk@fhs.mcmaster.ca
Whelan
D
D
Hill
R E
RE
Clarke
J T
JT
Pollitt
R J
RJ
D015094:3-Hydroxyacyl CoA Dehydrogenases / Q000172:deficiency* / Q000235:genetics; D000082:Acetaminophen / Q000009:adverse effects*; D018712:Analgesics, Non-Narcotic / Q000009:adverse effects*; D002331:Carnitine / Q000172:deficiency*; D005227:Fatty Acids / Q000378:metabolism; D006501:Hepatic Encephalopathy / Q000139:chemically induced / Q000235:genetics / Q000473:pathology; D006801:Humans; D006880:Hydroxy Acids / Q000652:urine*; D007223:Infant; D007662:Ketosis / Q000235:genetics / Q000652:urine; D017114:Liver Failure, Acute / Q000139:chemically induced / Q000235:genetics / Q000473:pathology; D008297:Male; D010084:Oxidation-Reduction
D018712:Analgesics, Non-Narcotic; D005227:Fatty Acids; D006880:Hydroxy Acids; D000082:Acetaminophen; D015094:3-Hydroxyacyl CoA Dehydrogenases; D002331:Carnitine